Annovis Bio, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.
The CEO of Annovis Bio commented in the following press release that, “No drug to date has shown efficacy in two totally different animal models of neurodegeneration. “In our AD animal studies, ANVS401 was shown to lower amyloid precursor protein (APP) and all its fragments, and animals fully recovered memory, learning, fear conditioning, and brain function. In our PD animal studies, ANVS401 lowered levels of α-synuclein and normalized gut motility in two transgenic animal models of PD. Together, these data are very exciting and provide strong support for moving forward in our development of ANVS401 for both AD and PD.” Read the full article.
Company Website: https://www.annovisbio.com